AdvaMed Says New Study Will Support Revamping Of Japan Reimbursement

This article was originally published in The Gray Sheet

07 Nov 2005
News

Executive Summary

A detailed study comparing the cost of bringing medical devices to market in Japan to that of doing so in the U.S. is due out soon from AdvaMed

Already Registered? Sign in to continue reading.

New to Medtech Insight? Start a free trial today!

Table
View full table

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

MT022854

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

MT022854

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

AdvaMed Says New Study Will Support Revamping Of Japan Reimbursement

News

Executive Summary

Related Content

AdvaMed President Ubl Sets Ambitious FDA Performance, International Goals

AdvaMed President Ubl Sets Ambitious FDA Performance, International Goals

Chilly Japanese Medical Device Climate Draws Fire From Hill, Industry

Japan’s ’05 Reforms Will Increase Efficiency, Reflect ’04 Industry Effort

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert